Transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms in people with multiple sclerosis: Protocol of a single-arm feasibility study

Hawra B Al Dandan, Rose Galvin, Katie Robinson, Dorren McClurg, Susan Coote, Hawra B Al Dandan, Rose Galvin, Katie Robinson, Dorren McClurg, Susan Coote

Abstract

Background: Neurogenic lower urinary tract dysfunction (NLUTD) is common among people with multiple sclerosis (MS) with a pooled prevalence of 68.41% using self-report measures and 63.95% using urodynamic studies. Transcutaneous tibial nerve stimulation (TTNS) is a non-invasive option to manage bladder storage symptoms; however, the potential efficacy of TTNS among people with MS is based on a small number of studies with the absence of high-quality evidence relating to efficacy, and lack of clarity of the optimal electrical stimulation parameters and frequency, duration and number of treatment sessions. This study aims to assess whether TTNS is feasible and acceptable as a treatment for bladder storage symptoms in people with MS. Methods: We will use a single-arm experimental study to explore the feasibility and acceptability of TTNS in the treatment of bladder storage symptoms in MS. The CONSORT extension for pilot and feasibility studies will be followed to standardise the conduct and reporting of the study. The recruitment plan is twofold: 1) Open recruitment for people with MS through MS Ireland's communication channels; 2) recruitment from a convenience sample of people with MS who have previously participated in a qualitative interview study of urinary symptoms. We will assess recruitment/retention rates, the urinary symptoms changes and the effect on quality of life pre and post intervention using ICIQ-OAB, 3-day bladder diary, King's Health Questionnaire and collect self-reported data on adherence and adverse events. Acceptability of using TTNS will be evaluated at the end of intervention. This study has been reviewed and approved by the Education and Health Science's Faculty Research Ethics Committee, University of Limerick [2020_06_07_EHS]. Conclusion: It is anticipated that assessing the feasibility and acceptability of TTNS for storage bladder symptoms in MS will inform the development of a definitive randomised trial. Trial registration: ClinicalTrials.gov NCT04528784 27/08/2020.

Keywords: Multiple sclerosis; Neurogenic bladder; Tibial nerve stimulation.; feasibility study; urinary symptoms.

Conflict of interest statement

No competing interests were disclosed.

Copyright: © 2020 Al Dandan HB et al.

References

    1. Abrams P, Andersson KE, Apostolidis A, et al. : 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn. 2018;37(7):2271–2272. 10.1002/nau.23551
    1. Abrams P, Avery K, Gardener N, et al. : The international consultation on incontinence modular questionnaire: . J Urol. 2006;175(3 Pt 1):1063–1066; discussion 1066. 10.1016/S0022-5347(05)00348-4
    1. Abrams P, Cardozo L, Wagg A, et al. : Incontinence 6th Edition. ICI-ICS. International Continence Society, Bristol,2017.
    1. Aharony SM, Lam O, Corcos J: Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines. Can Urol Assoc J. 2017;11(1–2):61–64. 10.5489/cuaj.4058
    1. Al-Dandan HB: Transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms in people with multiple sclerosis: Protocol of a single-arm feasibility study.2020. 10.17605/
    1. Al-Dandan HB, Coote S, Mcclurg D: Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care. 2020;22(2):91–99. 10.7224/1537-2073.2019-030
    1. Al-Dandan HB, Galvin R, Mcclurg D, et al. : Management strategies for lower urinary tract symptoms (LUTS) among people with multiple sclerosis (MS): a qualitative study of the perspectives of people with MS and healthcare professionals [version 1; peer review: 2 approved]. HRB Open Res. 2019;2:31. 10.12688/hrbopenres.12960.1
    1. Amarenco G, Ismael SS, Even-Schneider A, et al. : Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003;169(6):2210–2215. 10.1097/
    1. Anghel LA, Farcas AM, Oprean RN: An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–122. 10.15386/mpr-1201
    1. Arya NG, Weissbart SJ: Central control of micturition in women: Brain-bladder pathways in continence and urgency urinary incontinence. Clin Anat. 2017;30(3):373–384. 10.1002/ca.22840
    1. Bø K, Kvarstein B, Nygaard I: Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol. 2005;105(5 Pt 1):999–1005. 10.1097/01.AOG.0000157207.95680.6d
    1. Booth J, Connelly L, Dickson S, et al. : The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Neurourol Urodyn. 2018;37(2):528–541. 10.1002/nau.23351
    1. Browne C, Salmon N, Kehoe M: Bladder dysfunction and quality of life for people with multiple sclerosis. Disabil Rehabil. 2015;37(25):2350–2358. 10.3109/09638288.2015.1027007
    1. Burton C, Sajja A, Latthe PM: Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–1216. 10.1002/nau.22251
    1. Castel-Lacanal E: Sites of electrical stimulation used in neurology. Ann Phys Rehabil Med. 2015;58(4):201–207. 10.1016/j.rehab.2015.05.004
    1. Chancellor MB, Chartier-Kastler EJ: Principles of Sacral Nerve Stimulation (SNS) for the Treatment of Bladder and Urethral Sphincter Dysfunctions. Neuromodulation. 2000;3(1):16–26. 10.1046/j.1525-1403.2000.00015.x
    1. Chapple CR, Khullar V, Gabriel Z, et al. : The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol. 2008;54(3):543–562. 10.1016/j.eururo.2008.06.047
    1. Choudhary M, van Mastrigt R, van Asselt E: Inhibitory effects of tibial nerve stimulation on bladder neurophysiology in rats. SpringerPlus. 2016;5:35. 10.1186/s40064-016-1687-6
    1. Cruz F, Herschorn S, Aliotta P, et al. : Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial. Eur Urol. 2011;60(4):742–750. 10.1016/j.eururo.2011.07.002
    1. de Groat WC: A neurologic basis for the overactive bladder. Urology. 1997;50(6A Suppl):36–52; discussion 53–6. 10.1016/s0090-4295(97)00587-6
    1. de Sèze M, Raibaut P, Gallien P, et al. : Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011;30(3):306–11. 10.1002/nau.20958
    1. Denys P, Del Popolo G, Amarenco G, et al. : Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport ® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study. Neurourol Urodyn. 2017;36(2):457–462. 10.1002/nau.22954
    1. Devane LA, Evers J, Jones JFX, et al. : A review of sacral nerve stimulation parameters used in the treatment of faecal incontinence. Surgeon. 2015;13(3):156–162. 10.1016/j.surge.2014.11.002
    1. Eldridge SM, Chan CL, Campbell MJ, et al. : CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2:64. 10.1186/s40814-016-0105-8
    1. Finazzi-Agrò E, Rocchi C, Pachatz C, et al. : Percutaneous tibial nerve stimulation produces effects on brain activity: Study on the modifications of the long latency somatosensory evoked potentials. Neurourol Urodyn. 2009;28(4):320–324. 10.1002/nau.20651
    1. Finlayson ML, Peterson EW, Cho CC: Risk Factors for Falling Among People Aged 45 to 90 Years With Multiple Sclerosis. Arch Phys Med Rehabil. 2006;87(9):1274–1279; quiz 1287. 10.1016/j.apmr.2006.06.002
    1. Fowler CJ, Panicker JN, Drake M, et al. : A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80(5):470–7. 10.1136/jnnp.2008.159178
    1. Gajewski JB, Schurch B, Hamid R, et al. : An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD. Neurourol Urodyn. 2018;37(3):1152–1161. 10.1002/nau.23397
    1. Gaziev G, Topazio L, Lacovelli V, et al. : Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13:61. 10.1186/1471-2490-13-61
    1. Groen J, Pannek J, Diaz DC, et al. : Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol. 2016;69(2):324–33. 10.1016/j.eururo.2015.07.071
    1. Haylen BT, de Ridder D, Freeman RM, et al. : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26. 10.1007/s00192-009-0976-9
    1. Janssen DA, Martens FMJ, De Wall LL, et al. : Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives. Med Devices (Auckl). 2017;10:109–122. 10.2147/MDER.S115678
    1. Jaqua K, Powell CR: Where Are We Headed with Neuromodulation for Overactive Bladder? Curr Urol Rep. 2017;18(8):59. 10.1007/s11934-017-0711-x
    1. Jimenez-Cidre MA, Lopez-Fando L, Esteban-Fuertes M, et al. : The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women. Neurourol Urodyn. 2015;34(2):128–32. 10.1002/nau.22530
    1. Joussain C, Denys P: Electrical management of neurogenic lower urinary tract disorders. Ann Phys Rehabil Med. 2015;58(4):245–250. 10.1016/j.rehab.2015.07.005
    1. Kalsi V, Gonzales G, Popat R, et al. : Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol. 2007;62(5):452–7. 10.1002/ana.21209
    1. Kayes NM, Mcpherson KM, Schluter P, et al. : Exploring the facilitators and barriers to engagement in physical activity for people with multiple sclerosis. Disabil Rehabil. 2011;33(12):1043–1053. 10.3109/09638288.2010.520801
    1. Kelleher CJ, Pleil AM, Reese PR, et al. : How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder. BJOG. 2004;111(6):605–612. 10.1111/j.1471-0528.2004.00129.x
    1. Learmonth YC, Motl RW, Sandroff BM, et al. : Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013;13:37. 10.1186/1471-2377-13-37
    1. Li LF, Ka-Kit LG, Lui WM: Sacral Nerve Stimulation for Neurogenic Bladder. World Neurosurg. 2016;90:236–243. 10.1016/j.wneu.2016.02.108
    1. Mcclurg D, Ashe RG, Marshall K, et al. : Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn. 2006;25(4):337–48. 10.1002/nau.20209
    1. Mccombe PA, Gordon TP, Jackson MW: Bladder dysfunction in multiple sclerosis. Expert Rev Neurother. 2009;9(3):331–40. 10.1586/14737175.9.3.331
    1. Mcguire EJ, Shi-Chun Z, Horwinski ER, et al. : Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129(1):78–79. 10.1016/s0022-5347(17)51928-x
    1. Mehnert U, Birzele J, Reuter K, et al. : The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study. J Urol. 2010;184(3):1011–1016. 10.1016/j.juro.2010.05.035
    1. Monteiro ÉS, De Carvalho LBC, Fukujima MM, et al. : Electrical Stimulation of the Posterior Tibialis Nerve Improves Symptoms of Poststroke Neurogenic Overactive Bladder in Men: A Randomized Controlled Trial. Urology. 2014;84(3):509–514. 10.1016/j.urology.2014.05.031
    1. Nakipoglu GF, Kaya AZ, Orhan G, et al. : Urinary dysfunction in multiple sclerosis. J Clin Neurosci. 2009;16(10):1321–1324. 10.1016/j.jocn.2008.12.012
    1. Nambiar A, Lucas M: Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). Neurourol Urodyn. 2014;33 Suppl 3:S21–5. 10.1002/nau.22631
    1. Nortvedt MW, Riise T, Myhr KM, et al. : Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler. 2001;7(4):231–235. 10.1177/135245850100700404
    1. Notte SM, Marshall TS, Lee M, et al. : Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder. BMC Urol. 2012;12:26. 10.1186/1471-2490-12-26
    1. Okamura K, Nojiri Y, Osuga Y: Reliability and validity of the Kings Health Questionnaire for lower urinary tract symptoms in both genders. BJU Int. 2009;103(12):1673–1678. 10.1111/j.1464-410X.2008.08335.x
    1. Panicker JN, Fowler CJ: Lower urinary tract dysfunction in patients with multiple sclerosis. Handb Clin Neurol. 2015;130:371–81. 10.1016/B978-0-444-63247-0.00021-3
    1. Panicker JN, Fowler CJ, Kessler TM: Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14(7):720–732. 10.1016/S1474-4422(15)00070-8
    1. Pat Ray R, Andreas MP, Gary JO, et al. : Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder. Qual Life Res. 2003;12(4):427–442. 10.1023/a:1023422208910
    1. Perissinotto MC, D'ancona CAL, Lucio A, et al. : Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2015;42(1):94–99. 10.1097/WON.0000000000000078
    1. Peter TD, Peter MM: Neurogenic Bladder. Adv Urol. 2012;2012: 816274. 10.1155/2012/816274
    1. Prasad TS, Subahani J, Amirtha B: Assessment of efficacy of home available reminders to aid in the adherence and effectiveness of home-based pelvic floor muscle training in the management of stress urinary incontinence. IAIM. 2019;6(9):7–12.
    1. Robertson VJ, Low J, Reed A, et al. : Electrotherapy explained: principles and practice. Edinburgh; London: Butterworth-Heinemann Elsevier.2006.
    1. Sacomori C, Zomkowski K, Dos Passos Porto I, et al. : Adherence and effectiveness of a single instruction of pelvic floor exercises: a randomized clinical trial. Int Urogynecol J. 2019;31(5):951–959. 10.1007/s00192-019-04032-6
    1. Sahai A, Dowson C, Khan MS, et al. : Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity. Urology. 2010;75(3):552–558. 10.1016/j.urology.2009.05.097
    1. Sand PK, Sand RI: The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients. Dis Mon. 2013;59(7):261–268. 10.1016/j.disamonth.2013.03.013
    1. Schneider MP, Gross T, Bachmann LM, et al. : Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review. Eur Urol. 2015;68(5):859–67. 10.1016/j.eururo.2015.07.001
    1. Seth J, Haslam C, Gonzales G, et al. : SINGLE CENTRE RANDOMISED PILOT STUDY OF TWO REGIMENS (30 MINS DAILY OR 30 MINS WEEKLY FOR 12 WEEKS) OF TRANSCUTANEOUS TIBIAL NERVE STIMULATION USING A NOVEL DEVICE FOR TREATING MULTIPLE SCLEROSIS-RELATED OVERACTIVE BLADDER SYMPTOMS. BMJ Publishing Group Ltd.2015.
    1. Seth JH, Gonzales G, Haslam C, et al. : Feasibility of using a novel non-invasive ambulatory tibial nerve stimulation device for the home-based treatment of overactive bladder symptoms. Transl Androl Urol. 2018;7(6):912–919. 10.21037/tau.2018.09.12
    1. Slovak M, Chapple CR, Barker AT: Non-invasive transcutaneous electrical stimulation in the treatment of overactive bladder. Asian J Urol. 2015;2(2):92–101. 10.1016/j.ajur.2015.04.013
    1. Stöhrer M, Blok B, Castro-Diaz D, et al. : EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction. Eur Urol. 2009;56(1):81–88. 10.1016/j.eururo.2009.04.028
    1. Tornic J, Panicker J: The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis. Curr Neurol Neurosci Rep. 2018;18(8):54. 10.1007/s11910-018-0857-z
    1. Tudor KI, Seth JH, Liechti MD, et al. : Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder. Clin Auton Res. 2020;30(1):61–67. 10.1007/s10286-018-0553-8
    1. Valles-Antuna C, Perez-Haro Ml, Gonzalez-Ruiz De LC, et al. : Transcutaneous stimulation of the posterior tibial nerve for treating refractory urge incontinence of idiopathic and neurogenic origin. Actas Urol Esp. 2017;41(7):465–470. 10.1016/j.acuro.2017.01.009
    1. Vargas Luna Jl, Krenn M, Mayr W, et al. : Optimization of Interphase Intervals to Enhance the Evoked Muscular Responses of Transcutaneous Neuromuscular Electrical Stimulation. Artif Organs. 2017;41(12):1145–1152. 10.1111/aor.12921
    1. Vitkova M, Rosenberger J, Krokavcova M, et al. : Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction. Disabil Rehabil. 2014;36(12):987–992. 10.3109/09638288.2013.825332
    1. Woodwar S: Current management of neurogenic bladder in patients with MS. Br J Nurs. 2004;13(7):362–370. 10.12968/bjon.2004.13.7.12679
    1. Zappavigna C, Carr LK: Validated Questionnaires for the Evaluation of Urinary Incontinence—Which, When and Why? Curr Bladder Dysfunct Rep. 2015;10:138–142. 10.1007/s11884-015-0290-y
    1. Zecca C, Digesu GA, Robshaw P, et al. : Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice. Eur J Neurol. 2014;21(3):506–11. 10.1111/ene.12339
    1. Zecca C, Panicari L, Disanto G, et al. : Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Int Urogynecol J. 2016;27(4):521–527. 10.1007/s00192-015-2814-6
    1. : Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol.2010;183(4) : 10.1016/j.juro.2009.12.036 1438-43 10.1016/j.juro.2009.12.036

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa